Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.58% | 149.06 | 0.7% | $734.24m | |
| BMY | Bristol-Myers Squibb Co. | -0.08% | 66.73 | 1.0% | $726.64m | |
| PFE | Pfizer Inc. | -0.25% | 40.51 | 0.9% | $611.72m | |
| MRK | Merck & Co., Inc. | -0.22% | 90.98 | 0.7% | $577.92m | |
| ABBV | AbbVie, Inc. | -1.40% | 88.01 | 2.3% | $545.73m | |
| LLY | Eli Lilly & Co. | -1.29% | 139.61 | 1.1% | $400.65m | |
| APLS | Apellis Pharmaceuticals, Inc. | 0.30% | 40.50 | 0.0% | $107.43m | |
| NVS | Novartis AG | 0.88% | 95.94 | 0.2% | $101.60m | |
| AZN | AstraZeneca Plc | 1.62% | 51.33 | 1.2% | $98.49m | |
| GSK | GlaxoSmithKline Plc | 1.55% | 47.89 | 0.2% | $84.36m | |
| KRTX | Karuna Therapeutics, Inc. | 9.17% | 104.52 | 0.0% | $68.78m | |
| SNY | Sanofi | 0.10% | 51.24 | 0.2% | $68.67m | |
| NVO | Novo Nordisk A/S | -0.02% | 61.30 | 0.1% | $64.41m | |
| RETA | Reata Pharmaceuticals, Inc. | -2.24% | 211.43 | 3.5% | $64.03m | |
| TPTX | Turning Point Therapeutics, Inc. | 2.72% | 59.95 | 0.0% | $40.48m |
Company Profile
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.